Drug Type Synthetic peptide vaccine, Therapeutic vaccine |
Synonyms Peptide-based cancer vaccine, ONO 7268MX2, ONO-7268MX2 + [1] |
Target- |
Mechanism Immunostimulants |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hepatocellular Carcinoma | Phase 1 | - | - | |
Hepatocellular Carcinoma | Phase 1 | - | - | |
Hepatocellular Carcinoma | Phase 1 | - | - | |
Liver Cancer | Phase 1 | JP | - |
Phase 1 | - | (ONO-7268MX1) | qisyqwbxvr(odecgiisfc) = Grade 3-related AEs occurred only in MX2 study; decreased appetite uwniafdazt (ydjufzgior ) View more | - | 26 Feb 2018 | ||
(ONO-7268MX2) |